Cargando…
Genomic and Immunological Characterization of Pyroptosis in Lung Adenocarcinoma
Pyroptosis is a programmed cell death that may either promote or hinder cancer growth under different circumstances. Pyroptosis-related genes (PRGs) could be a useful target for cancer therapy, and are uncommon in lung adenocarcinoma (LUAD). The expression profiles, mutation data and clinical inform...
Autores principales: | Song, Yaobo, Qu, Zhen, Feng, Hu, Xu, Long, Xiao, Yajie, Zhao, Zhikun, Wu, Dongfang, Sun, Chao, Fan, Xinglong, Zhou, Dongmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348947/ https://www.ncbi.nlm.nih.gov/pubmed/35938142 http://dx.doi.org/10.1155/2022/6905588 |
Ejemplares similares
-
Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian Cancer
por: Zhou, Min, et al.
Publicado: (2021) -
Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
por: Li, Kang, et al.
Publicado: (2022) -
Understanding the Critical Role of Glycolysis-Related lncRNAs in Lung Adenocarcinoma Based on Three Molecular Subtypes
por: Cao, Peng, et al.
Publicado: (2022) -
Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report
por: Wu, Licheng, et al.
Publicado: (2020) -
287 Genomic and Immunologic Characterization of Lung Adenocarcinoma in Never Smokers vs. Smokers
por: Li, P. Jonathan, et al.
Publicado: (2023)